RxDoctor Payments Data

Jody Pryor, APRN

Family · El Dorado Springs, MONPI 1629602024

Payments from drug & device makers

$693in general payments, 2019–2025

Across 42 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$152
  • Novo Nordisk$85
  • Otsuka America Pharmaceutical, Inc.$69
  • Lilly USA, LLC$63
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$58
  • Melinta Therapeutics, LLC$39
  • plus $228 from 10 others

What the payments were for

  • Food & beverage$693100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$693 in reported general payments places this provider in the 60th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$11,553
Medicare patients
55
Services billed
1,328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole15$25,311
OzempicSemaglutide12$12,720
JardianceEmpagliflozin18$10,624
MyrbetriqMirabegron22$9,438
EliquisApixaban14$8,357
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,633
Advair HfaFluticasone Propion/Salmeterol17$7,122
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,095
Albuterol Sulfate HfaAlbuterol Sulfate48$1,649
Vilazodone Hcl13$1,601
Gabapentin104$1,173
Duloxetine Hcl52$842
Pantoprazole Sodium72$776
Potassium Chloride38$637
Atorvastatin Calcium85$590

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$69$25,31115 claims
Novo NordiskOzempic$85$12,72012 claims
Boehringer IngelheimJardiance$14$10,62418 claims
PfizerEliquis$37$8,35714 claims
AstraZenecaBreztri Aerosphere$30$7,63312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,812 family providers in Missouri.

Other family in El Dorado Springs

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →